---
title: Farnesoid X receptor activation inhibits pancreatic carcinogenesis
date: '2023-07-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37515840/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230730180744&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Farnesoid X receptor (FXR), a member of the nuclear receptor superfamily
  that controls bile acid (BA) homeostasis, has also been proposed as a tumor suppressor
  for breast and liver cancer. However, its role in pancreatic ductal adenocarcinoma
  (PDAC) tumorigenesis remains controversial. We recently found that FXR attenuates
  acinar cell autophagy in chronic pancreatitis resulting in reduced autophagy and
  promotion of pancreatic carcinogenesis. Feeding Kras-p48-Cre (KC) mice with the
  ...
disable_comments: true
---
Farnesoid X receptor (FXR), a member of the nuclear receptor superfamily that controls bile acid (BA) homeostasis, has also been proposed as a tumor suppressor for breast and liver cancer. However, its role in pancreatic ductal adenocarcinoma (PDAC) tumorigenesis remains controversial. We recently found that FXR attenuates acinar cell autophagy in chronic pancreatitis resulting in reduced autophagy and promotion of pancreatic carcinogenesis. Feeding Kras-p48-Cre (KC) mice with the ...